If you need medical help and are unsure what to do, call NHS 111 for help and advice. They are available 24 hours a day.
POC Prescribing Guidelines
The Prescribing Oversight Committee is a Berkshire West Integrated Care Partnership committee representing Primary and Secondary Care across West Berkshire
Prescribing Oversight Committee - Prescribing Guidelines
(previously known as the Area Prescribing Committee)
Please click here to go back to the POC Documents Homepage
- POC (APC) PG 001 - For the treatment and prevention of Venous Thromboembolic disease (DVT/PE)
- POC (APC) PG 002 - Azathioprine/6-Mercaptopurine for the treatment of Inflammatory Bowel Disease (IBD)
- APC PG 003 - Azathioprine for the treatment of inflammatory joint disease superseded by APC PG 037 (see below)
- APC PG 004 - Ciclosporin for the treatment of inflammatory joint disease superseded by APC PG 037 (see below)
- POC (APC) PG 005 - Cinacalcet for the treatment of secondary hyperparathyroidism
- POC (APC) PG 006 - Denosumab for the treatment of osteoporosis in men and postmenopausal women at increased risk of fractures
- POC (APC) PG 007 - Fidaxomicin for the treatment of recurrent Clostridium difficile infection (CDI)
- APC PG 008 - Gold therapy for the treatment of inflammatory joint disease superseded by APC PG 037 (see below)
- APC PG 009 - Leflunomide for the treatment of inflammatory joint disease superseded by APC PG 037 (see below)
- POC (APC) PG 010a - Lithium Prescribing Arrangements
- POC (APC) PG 012 - BHFT Methadone for refractory pain
- POC (APC) PG 013 - Mycophenolate mofetil (MMF) for the treatment of inflammatory joint disease
- POC (APC) PG 014 - Non-calcium based binders Lanthanum Carbonate and Sevelamer Carbonate or Hydrochloride for the treatment of hyperphosphatemia in adults with chronic kidney disease
- POC (APC) PG 015a - Cholinesterase Inhibitors / Memantine Prescribing Arrangements
- POC (APC) PG 016 - Prescribing Arrangements for Patients Prescribed Long Acting Injectable (LAI) Antipsychotics
- POC (APC) PG 017 - Primary care prescribing arrangements for midodrine (Bramox®) for use in orthostatic hypotension and Postural Tachycardia Syndrome (PoTS)
- POC (APC) PG 018 - Methotrexate for the treatment of Inflammatory Bowel Disease
- POC (APC) PG 019 - Mycophenolate Mofetil for the treatment of lupus nephritis and systemic vasculitis
- POC (APC) PG 020 - Sacubitril valsartan for the treatment of symptomatic heart failure
- POC (APC) PG 021 - Prescribing Guideline for amantadine for the treatment of fatigue in Multiple Sclerosis
- POC (APC) PG 022 - Azathioprine for the treatment of vasculitis
- POC (APC) PG 023 - Methotrexate for the treatment of vasculitis
- POC (APC) PG 024 - Tacrolimus for the treatment of Nephrotic Syndrome
- APC PG 025 - Rheumatology Department DMARD Monitoring Guidelines for Methotrexate superseded by POC (APC) PG 037 (see below)
- POC (APC) PG 026 - Hydroxycarbamide for Polycythaemia Vera, Myelofibrosis and Essential Thrombocythaemia
- POC (APC) PG 027 - Nebulised tobramycin for the treatment Pseudomonas colonised (non cystic fibrosis) bronchiectasis, intolerant of, or deterioration on, long term nebulised Colomycin
- POC (APC) PG 028 - Nebulised colomycin for the treatment Pseudomonas colonised (non cystic fibrosis) bronchiectasis
- POC (APC) PG 029 - Human Growth Hormone (somatropin)
- POC (APC) PG 030 - The use of GnRH Agonists in Central Precocious Puberty (CPP)
- POC (APC) PG 031 - Topical tacrolimus (Protopic) for the treatment of moderate to severe atopic dermatitis in adults not responding to conventional therapies
- POC (APC) PG 032 - Tinzaparin for Prophylaxis of Venous Thromboembolism during Pregnancy and the Puerperium
- POC (APC) PG 033 - Tacrolimus for the treatment of Inflammatory Bowel Disease (IBD)
- POC (APC) PG 034 - Sucroferric Oxyhydroxide for hyperphosphataemia in adults with chronic kidney disease
- POC (APC) PG 037 - DAWN Prescribing Guideline Process Summary
- POC (APC) PG 038 - Liothyronine for a selected cohort of adults with Hypothyroidism